Effectiveness of BNT162b2 vaccine against SARS-CoV-2 among healthcare workers Effectiveness of HCWs vaccination against SARS-CoV-2

Main Article Content

Emanuele Sansone
Emma Sala
Mara Tiraboschi
Elisa Albini
Massimo Lombardo
Annamaria Indelicato
Cristina Rosati
Maria Beatrice Boniotti
Francesco Castelli
Giuseppe De Palma


COVID-19 Pandemic, Vaccination, Follow-up, Health Surveillance


Background: The present study was aimed at evaluating the effectiveness of BNT162b2 among HCWs of a university hospital while a recrudescence of pandemics was hitting the province, with a high rate of the B.1.1.7 variant. Methods: The study was performed in the context of health surveillance at the workplaces. We monitored the SARS-CoV-2 infection and COVID-19 symptoms among HCWs classified by having received the entire vaccine schedule or not; the latter further classified in not vaccinated workers and workers who had received the first shot more than 14 days earlier. The SARS-CoV-2 infection was diagnosed by conventional RT-PCR on rhino-pharyngeal swabs, followed by gene sequencing in positive vaccinated HCWs. The cumulative incidence of infections in the period was normalised to 100,000 people. Results: At the end of the observation period, HCWs that had completed the full schedule were at lower infection risk than both unvaccinated HCWs and the workforce who had not yet gained the complete theoretical protection from the vaccine (by 2.4-folds). Overall, ninety-two SARS-CoV-2 infections were observed among HCWs, mostly among not protected workers (52 cases) but none of them showed symptoms requiring hospitalisation. Conclusions: The vaccination campaign effectively reduced the appearance of symptoms and the incidence of infections among vaccinated HCWs. Among vaccinated HCWs, gene sequencing was possible in five cases only, 4 B.1.1.7 and 1 B1.525 variants. The high rate of unsuccessful gene sequencing observed among infected vaccinated workers could be explained by a low viral burden. Vaccination for COVID-19 should be mandatory in occupational settings with a high infective risk.


Download data is not yet available.
Abstract 569 | PDF Downloads 294


Boffetta P, Violante F, Durando P, et al. Determinants of SARS-CoV-2 infection in Italian healthcare workers: a multicenter study. Sci Rep. 2021;11(1):5788. doi:10.1038/s41598-021-85215-4
Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615. doi:10.1056/NEJMoa2034577
Benenson S, Oster Y, Cohen MJ, Nir-Paz R. BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers [published online ahead of print, 2021 Mar 23]. N Engl J Med. 2021;NEJMc2101951. doi:10.1056/NEJMc2101951
Daniel W, Nivet M, Warner J, Podolsky DK. Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center. N Engl J Med. 2021 Mar 23:NEJMc2102153. doi: 10.1056/NEJMc2102153. Epub ahead of print. PMID: 33755374; PMCID: PMC8008752.
Keehner J, Horton LE, Pfeffer MA, et al. SARS-CoV-2 Infection after Vaccination in Health Care Workers in California [published online ahead of print, 2021 Mar 23]. N Engl J Med. 2021;NEJMc2101927. doi:10.1056/NEJMc2101927
Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 1 April, 2020
ECDC Technical report 3 Mar 2021. Methods for the detection and identification of SARS-CoV-2 variants, available at: https://www.ecdc.europa.eu/en/publications-data/methods-detection-and-identification-sars-cov-2-variants
Comelli A, Focà E, Sansone E, et al. Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy. Microorganisms 2021 Feb 25;9(3):488. doi: 10.3390/microorganisms9030488.
https://statistichecoronavirus.it/coronavirus-italia/ consulted on-line on April 1st 2021.
Shen X, Tang H, et al. SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines. bioRxiv.2021 Jan 29;2021.01.27.428516.
Lavine J S, Bjornstad O J, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science 12 Feb 2021 Vol. 371, Issue 6530, pp. 741-745